Enzyme Patent Dispute Settled For $8.2M
By Amanda Ernst ( February 20, 2007, 12:00 AM EST) -- Danish biotech company Danisco A/S will pay rival Novozymes A/S over $8.2 million to settle an ongoing patent infringement suit after a district court judge ruled Monday that Danisco willfully infringed Novozymes' patent for the enzyme Spezyme Ethyl....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.